FUTU:NASDAQFutu Holdings Limited Analysis
Data as of 2026-06-11 - not real-time
$92.93
Latest Price
8/10Risk
Risk Level: High
Executive Summary
FUTU is trading well below its longer‑term moving averages, with momentum indicators showing an oversold condition and a bearish MACD divergence. Technical signals suggest a potential short‑term rebound, but the stock is constrained by a recent regulatory investigation and an administrative penalty from Chinese authorities, which injects heightened uncertainty.
Fundamentally, the company delivers exceptional profitability margins, rapid revenue growth, and a strong cash position, while its valuation metrics (low PE relative to industry and modest price‑to‑book) point to an undervalued status. The dividend yield appears attractive, yet the payout ratio of zero raises questions about sustainability. Overall, the blend of solid fundamentals and elevated risk factors calls for a measured, phased approach to exposure.
Fundamentally, the company delivers exceptional profitability margins, rapid revenue growth, and a strong cash position, while its valuation metrics (low PE relative to industry and modest price‑to‑book) point to an undervalued status. The dividend yield appears attractive, yet the payout ratio of zero raises questions about sustainability. Overall, the blend of solid fundamentals and elevated risk factors calls for a measured, phased approach to exposure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Oversold RSI suggesting limited upside
- Bearish MACD and price below short‑term averages
- Regulatory investigation adding near‑term uncertainty
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth and high operating margins
- Undervalued valuation relative to peers
- Stable credit rating and robust cash reserves
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Expanding client assets and funded accounts
- Sustainable business model in digital brokerage
- Attractive dividend yield despite payout concerns
Key Metrics & Analysis
Financial Health
Revenue Growth28.80%
Profit Margin45.03%
P/E Ratio10.3
ROE27.84%
ROA4.68%
Debt/Equity54.25
P/B Ratio2.5
Industry P/E16.5
Technical Analysis
TrendBearish
RSI29.7
Support$80.50
Resistance$143.63
MA 20$110.24
MA 50$136.27
MA 200$159.33
MACDBearish
VolumeDecreasing
Fear & Greed Index84.27
Valuation
Target Price$163.81
Upside/Downside76.28%
GradeUndervalued
TypeGrowth
Dividend Yield2.80%
Risk Assessment
Beta2.25
Volatility122.51%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.